U.S. FDA Head Says First Of 60 Foreign Offices To Open In China This Year
This article was originally published in PharmAsia News
U.S. FDA plans to kick off a vast expansion of the agency's presence in other countries by opening its first office in China before the end of the year. Commissioner Andrew von Eschenbach said the first office in China will be among 60 the agency plans to establish abroad within the next year. India is getting a particular focus by the FDA, which also plans to focus on Latin America and the Middle East. He said in an interview the agency is trying to send a clear signal drug makers and other companies it oversees will not get access to the U.S. market unless their products comply with U.S. quality standards. (Click here for more - a subscription may be required
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.